Presenter: Heather Zwickey, PhD

Original Date: August 13, 2022

Irritable Bowel Syndrome (IBS) is a diagnosis that highlights the cross-talk between brain and gut. The microbial communities in the gut wield remarkable influence over human health and disease, including IBS. However, the complexity of the gut microbiota between individuals makes it challenging to identify putative causative agents of a particular disease phenotype. Microbial metabolites may provide IBS insights that the presence or absence of particular microbes cannot. In this seminar, we will evaluate the role of microbial metabolites, including bile acids, short-chain fatty acids, tryptophan derivatives and indole derivatives for their roles in IBS. As research around the microbiome and microbial metabolites grows, treating the cause of IBS may be more in reach.

1.5 General (Total 1.5 CEUs) approved by OBNM